STOXPO
  • Latest News
  • Technology
    • Software
    • Semiconductors
  • Healthcare
    • Biotechnology
    • Pharmaceuticals
  • Crypto
    • Altcoins
    • Bitcoin
    • Ethereum
  • Companies
    • Micro-Cap
    • Small-Cap
    • Mid-Cap
    • Large-Cap
    • Mega-Cap
  • Q&A’s
  • Contributions
No Result
View All Result
  • Latest News
  • Technology
    • Software
    • Semiconductors
  • Healthcare
    • Biotechnology
    • Pharmaceuticals
  • Crypto
    • Altcoins
    • Bitcoin
    • Ethereum
  • Companies
    • Micro-Cap
    • Small-Cap
    • Mid-Cap
    • Large-Cap
    • Mega-Cap
  • Q&A’s
  • Contributions
No Result
View All Result
STOXPO
No Result
View All Result
Home Healthcare Pharmaceuticals

Conduit and Sarborg Advance to Phase II of AI-Driven Drug Development

byLiliana Vida
February 7, 2025
in Pharmaceuticals, Small-Cap
Reading Time: 2 mins read
Share on TwitterShare on LinkedIn

Collaboration Shifts Focus to Personalized Software Dashboards for Enhanced Efficiency

Conduit Pharmaceuticals (CDT) announced the successful completion of Phase I in its AI-driven drug development collaboration with Sarborg Limited. With all milestones achieved, the partnership is now transitioning to Phase II, which will focus on developing personalized software dashboards to improve operational efficiency and decision-making.

Phase I, initiated in December 2024, laid the groundwork for integrating AI and cybernetics into Conduit’s drug development process. It involved aligning Sarborg’s AI-driven processes with Conduit’s portfolio needs, validating proprietary inputs, and conducting an in-depth market analysis of cocrystal candidates. The phase also established key algorithmic approaches aimed at optimizing drug repurposing, discovery, and clinical trial monitoring.

The transition to Phase II marks a strategic shift toward technological infrastructure development. Conduit and Sarborg will create AI-powered dashboards to provide real-time insights into clinical trials, drug discovery, and portfolio management. These tools are expected to enhance agility in decision-making and improve operational oversight, particularly in advancing treatments for autoimmune disorders.

With this next phase, Conduit continues its commitment to leveraging AI for innovation in drug development, aiming to optimize efficiency and accelerate the path to new therapies.

Read original press release here

You might like this article:Tesla’s China Sales Drop in January as BYD Gains Ground

Tags: CDTConduitGrowthMoversNews
Previous Post

Tesla’s China Sales Drop in January as BYD Gains Ground

Next Post

Doximity Reports Strong Q3 Earnings with 25% Revenue Growth

Related Posts

trading-chart-2

BitMine Raises $250 Million to Launch One of the Largest Public Ether Treasuries

byLuca Blaumann
June 30, 2025
0

Ethereum-focused strategy attracts top crypto investors as BitMine stock surges on bold treasury pivot BitMine Immersion Technologies (BMNR) has announced...

EXCLUSIVE: MIRA Pharmaceuticals’ Disruptive Path In Neurology And Metabolic Disorders

byLiliana Vida
June 30, 2025
0

CEO Erez Aminov on Breakthrough Drug Candidates, Strategic Acquisitions, and the Vision Behind MIRA’s Innovation-Driven Pipeline MIRA Pharmaceuticals (NASDAQ: MIRA),...

ev-charging-3

Ideal Power Advances Commercialization of B-TRAN® Technology with New EV Industry Order

byLuca Blaumann
June 26, 2025
0

Tier 1 Automotive Supplier to Evaluate B-TRAN® for Next-Generation Solid-State EV Contactor Applications Ideal Power (IPWR), a leading developer of...

Next Post
trading-chart

Doximity Reports Strong Q3 Earnings with 25% Revenue Growth

Latest News

CrowdStrike Hits Record High After Wedbush Declares It Cybersecurity’s “Gold Standard”

OpenAI Secures 4.5 GW of Data Center Power From Oracle in Record-Breaking Deal

Footwear Stocks Rise After Trump Announces Vietnam Trade Deal

Circle Applies for U.S. Trust Bank Charter to Strengthen Stablecoin Strategy

Robinhood Launches Tokenized Stocks in EU, Expands Crypto Offerings Globally

Based on Your Interest

trading-chart-2
Altcoins

BitMine Raises $250 Million to Launch One of the Largest Public Ether Treasuries

June 30, 2025
trading-chart
IT Services

Oracle Secures Massive $30 Billion Cloud Deal, Signaling Major Market Expansion

June 30, 2025
Blog

EXCLUSIVE: MIRA Pharmaceuticals’ Disruptive Path In Neurology And Metabolic Disorders

June 30, 2025

Recommended

Large-Cap

Nike Shares Surge Despite $1 Billion Tariff Hit and Imminent U.S. Price Hikes

June 27, 2025
Bitcoin

CoreWeave Reignites Acquisition Talks With Core Scientific Amid Rising Demand for Computing Power

June 26, 2025
Mid-Cap

Shake Shack Sizzles as Analysts Raise Price Targets on Growth and Leadership Optimism

June 26, 2025
Semiconductors

Ideal Power Advances Commercialization of B-TRAN® Technology with New EV Industry Order

June 26, 2025
Internet

Meta Hires OpenAI’s Trapit Bansal to Bolster AI Superintelligence Team

June 26, 2025
Stoxpo

Follow us on social media:

Highlights

  • CrowdStrike Hits Record High After Wedbush Declares It Cybersecurity’s “Gold Standard”
  • OpenAI Secures 4.5 GW of Data Center Power From Oracle in Record-Breaking Deal
  • Footwear Stocks Rise After Trump Announces Vietnam Trade Deal
  • Circle Applies for U.S. Trust Bank Charter to Strengthen Stablecoin Strategy
  • Robinhood Launches Tokenized Stocks in EU, Expands Crypto Offerings Globally

Category

  • Blog
  • Communication Services
    • Entertainment
    • Internet
    • Telecommunications
  • Companies
    • Large-Cap
    • Mega-Cap
    • Micro-Cap
    • Mid-Cap
    • Small-Cap
  • Consumer Cyclical
    • Auto Manufacturers
    • Casinos & Gambling
    • Ground Transportation
    • Hospitality
      • Casinp
      • Resorts & Lodging
      • Restaurants
      • Travel
        • Airlines
    • Retail
    • Textiles, Apparel & Luxury Goods
  • Consumer Defensive
    • Beverages
    • Discount Stores
    • Distributor
    • Ecommerece
    • Electrical Equipment
    • Foods
    • Household & Personal Products
    • Leisure Products
    • Tobacco
  • Contributions
  • Crypto
    • Altcoins
    • Bitcoin
    • Ethereum
  • Economy
  • Energy
    • Electric
    • Oil & Gas
    • Renewables
  • Financial Services
    • Asset Management
    • Banks
    • Brokerages
    • Credit Services
    • Insurance
  • Healthcare
    • Biotechnology
    • Medical Devices
    • Pharmaceuticals
  • Industrials
    • Aerospace & Defense
    • Construction
    • Industrial Machinery
  • Materials
    • Building Materials
    • Chemicals
    • Gold
    • Mining
    • Silver
    • Steel
  • Q&A's
  • Real Estate
  • Technology
    • Artificial Intelligence
    • Computer Hardware
    • Consumer Electronics
    • Cybersecurity
    • IT Services
    • Semiconductors
    • Software
  • Utilities

Latest News

CrowdStrike Hits Record High After Wedbush Declares It Cybersecurity’s “Gold Standard”

July 3, 2025

OpenAI Secures 4.5 GW of Data Center Power From Oracle in Record-Breaking Deal

July 3, 2025

Footwear Stocks Rise After Trump Announces Vietnam Trade Deal

July 2, 2025
  • About
  • Privacy Policy
  • Contact

© 2024 All Rights Reserved: STOXPO.

No Result
View All Result
  • Latest News
  • Healthcare
    • Biotechnology
    • Pharmaceuticals
  • Technology
    • Software
    • Semiconductors
  • Crypto
    • Bitcoin
    • Ethereum
    • Altcoins
  • Companies
    • Micro-Cap
    • Small-Cap
    • Mid-Cap
    • Large-Cap
    • Mega-Cap
  • Q&A’s
  • Contributions

© 2024 All Rights Reserved: STOXPO.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Read More

In case of sale of your personal information, you may opt out by using the link Do Not Sell My Personal Information

Accept Cookie Settings
Cookies are small text files that can be used by websites to make a user's experience more efficient. The law states that we can store cookies on your device if they are strictly necessary for the operation of this site. For all other types of cookies we need your permission. This site uses different types of cookies. Some cookies are placed by third party services that appear on our pages.
  • Always Active
    Necessary
    Necessary cookies help make a website usable by enabling basic functions like page navigation and access to secure areas of the website. The website cannot function properly without these cookies.
  • Marketing
    Marketing cookies are used to track visitors across websites. The intention is to display ads that are relevant and engaging for the individual user and thereby more valuable for publishers and third party advertisers.
  • Analytics
    Analytics cookies help website owners to understand how visitors interact with websites by collecting and reporting information anonymously.
  • Preferences
    Preference cookies enable a website to remember information that changes the way the website behaves or looks, like your preferred language or the region that you are in.
  • Unclassified
    Unclassified cookies are cookies that we are in the process of classifying, together with the providers of individual cookies.
Cookie Settings

Do you really wish to opt-out?